Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1982 5
1983 5
1984 3
1990 1
1993 1
1998 1
1999 1
2001 1
2002 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L. Bluefarb SM, et al. J Int Med Res. 1976;4(6):454-61. doi: 10.1177/030006057600400613. J Int Med Res. 1976. PMID: 800385 Free article. Clinical Trial.
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinonide, beta-methasone 17-valerate and fluocinolone acetonide) when the compounds were dissolved in 95% alcohol and applied in vasoconstrictor
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinon
A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Kaidbey K, Kopper SC, Sefton J, Gibson JR. Kaidbey K, et al. Int J Dermatol. 2001 Jul;40(7):468-71. doi: 10.1046/j.1365-4362.2001.01234.x. Int J Dermatol. 2001. PMID: 11679006 Clinical Trial.
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to each of six sites on their forearms: no treatment, tazarotene vehicle, tazarotene vehicle + tazarotene gel 0.1%, diflorasone diaceta …
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to …
Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
Johansson EA, Stiger TR. Johansson EA, et al. Curr Med Res Opin. 1984;9(4):259-64. doi: 10.1185/03007998409109589. Curr Med Res Opin. 1984. PMID: 6510015 Clinical Trial.
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study earlier because of total (100%) improvement of lesions. ...At Week 3, this difference in the improvement of pruritus was marginally significa …
Altogether 32 patients completed the 3-week study. Fourteen patients in the diflorasone group and 6 on betamethasone left the study e …
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Leibsohn E. Leibsohn E. J Int Med Res. 1982;10(1):22-7. doi: 10.1177/030006058201000104. J Int Med Res. 1982. PMID: 7073809 Free article. Clinical Trial.
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic, were treated with either diflorasone diacetate ointment 0.05% or betamethasone dipropionate ointment 0.05% twice a day for 3 weeks. …
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic …
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Green L, Sadoff W. Green L, et al. J Cutan Med Surg. 2002 Mar-Apr;6(2):95-102. doi: 10.1007/s10227-001-0031-z. Epub 2002 Feb 13. J Cutan Med Surg. 2002. PMID: 11992180 Clinical Trial.
METHODS: A 12-week, multicenter, investigator-masked, randomized, parallel-group study was performed with more than 200 patients who were randomly assigned to regimens of tazarotene 0.1% gel alone, tazarotene plus a high-potency topical corticosteroid (fluocinonide 0.05% ointment …
METHODS: A 12-week, multicenter, investigator-masked, randomized, parallel-group study was performed with more than 200 patients who were ra …
An evaluation of once-daily applications of diflorasone diacetate in eczematous dermatoses.
Squires DJ, Masson EL. Squires DJ, et al. J Int Med Res. 1981;9(1):79-81. doi: 10.1177/030006058100900114. J Int Med Res. 1981. PMID: 7009258 Free article. Clinical Trial.
The efficacy of once-daily applications of 0.05% diflorasone diacetate in a cream or ointment formulation was evaluated in a 3-week study of 301 patients with eczematous dermatoses. ...
The efficacy of once-daily applications of 0.05% diflorasone diacetate in a cream or ointment formulation was evaluated in a 3-week s …
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Krueger GG, O'Reilly MA, Weidner M, Dromgoole SH, Killey FP. Krueger GG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):186-90. doi: 10.1016/s0190-9622(98)70238-5. J Am Acad Dermatol. 1998. PMID: 9486672 Clinical Trial.
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. METHODS: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-comparison s …
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diaceta …
Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL, Jondreau L, Kenny C, Stiller MJ. Shupack JL, et al. Dermatology. 1993;186(2):129-32. doi: 10.1159/000247323. Dermatology. 1993. PMID: 8428041 Clinical Trial.
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, diflorasone diacetate 0.05% and betamethasone dipropionate 0.05%, in psoriatic adults. ...
We report the results of a 2-week double-blind, parallel clinical trial comparing two superpotent topical glucocorticosteroid ointments, …
[Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
Rozman TA, Wiedey KD, Renovanz HD. Rozman TA, et al. Z Hautkr. 1983 Mar 15;58(6):398-409. Z Hautkr. 1983. PMID: 6342288 Clinical Trial. German.
According to the physician's overall judgement, however, Clobetasol was favored significantly over Diflorasone-Diacetate, while the patients only showed a slight preference for Clobetasol. Based on these findings and previously published results, Diflorasone-Diaceta …
According to the physician's overall judgement, however, Clobetasol was favored significantly over Diflorasone-Diacetate, while the p …
Once daily application of diflorasone diacetate ointment compared with betamethasone valerate ointment twice daily in patients with eczematous dermatoses.
Hersle K, Mobacken H. Hersle K, et al. J Int Med Res. 1982;10(6):423-5. doi: 10.1177/030006058201000607. J Int Med Res. 1982. PMID: 7152081 Free article. Clinical Trial.
The clinical efficacy of 0.05% diflorasone diacetate applied once daily, for eczematous dermatoses, was compared with the twice daily application of betamethasone valerate. ...
The clinical efficacy of 0.05% diflorasone diacetate applied once daily, for eczematous dermatoses, was compared with the twice daily …
21 results